rs121917745
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2_SupportingPM3_StrongPP3_ModeratePS3_SupportingPP4_Moderate
This summary comes from the ClinGen Evidence Repository: NM_000329.3(RPE65):c.1543C>T is a missense variant predicted to replace arginine with tryptophan at position 515. This variant is present in gnomAD v.2.1.1 at a GrpMax allele frequency of 0.000002980, with 2 alleles / 126782 total alleles in the European (non-Finnish population), which is lower than the ClinGen LCA / eoRD VCEP PM2_Supporting threshold of <0.0002 (PM2_Supporting). This variant has been reported in at least 1 proband with early-onset severe retinal dystrophy who was homozygous for the variant (0.5 pts, PMID:25495949). This variant has also been reported in at least 4 probands with early-onset severe retinal dystrophy who were compound heterozygous with either the NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser) (PMID:34492281)), NM_000329.3(RPE65):c.1102T>C (p.Tyr368His) (PMID:32032261), NM_000329.3(RPE65):c.1067dup (p.Asn356fs) (PMID:35129589), or NM_000329.3(RPE65):c.130C>T (p.Arg44Ter) variant (PMID:30025081) variants suspected in trans (2 pts), which were all previously classified pathogenic by the ClinGen LCA / eoRD VCEP (2.5 total points, PM3_Strong). At least one proband harboring this variant exhibits a phenotype including diagnosis of Leber congenital amaurosis (0.5 pts) based on exome sequencing-based genotyping that did not provide an alternative explanation for visual impairment (2 pts), night blindness (0.5 pts) with onset during the first year of life (1 pt), attenuated retinal vessels (0.5 pts), macular atrophy (0.5 pts), bone spicule pigmentation (0.5 pts), non-recordable electroretinogram pattern in rod (0.5 pts) and cone (1 pt) responses, and decreased central visual acuity (1 pt), which together are highly specific for RPE65-related recessive retinopathy (8 total pts, PMID:25495949, PP4_Moderate). The computational predictor REVEL gives a score of 0.935, which is above the ClinGen LCA / eoRD VCEP threshold of ≥0.773 and predicts a damaging effect on RPE65 function (PP3_Moderate). The variant exhibited less than 10% enzymatic activity in a retinoid isomerase assay relative to the wild-type control, which is lower than the ClinGen LCA / eoRD PS3_Supporting threshold of <10% activity, indicating that it triggers a severe defect in protein function (PMID:25752820, PS3_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: PS3_Supporting, PM2_Supporting, PM3_Strong, PP3_Moderate, and PP4_Moderate. (VCEP specifications version 1.0.0; date of approval 09/21/2023). LINK:https://erepo.genome.network/evrepo/ui/classification/CA226519/MONDO:0100368/120
Frequency
Consequence
NM_000329.3 missense
Scores
Clinical Significance
Conservation
Publications
- Leber congenital amaurosis 2Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- retinitis pigmentosaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- RPE65-related recessive retinopathyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Ambry Genetics
- RPE65-related dominant retinopathyInheritance: AD Classification: STRONG Submitted by: ClinGen, PanelApp Australia
- retinitis pigmentosa 20Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- Leber congenital amaurosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-childhood-onset retinal dystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosa 87 with choroidal involvementInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000329.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RPE65 | MANE Select | c.1543C>T | p.Arg515Trp | missense | Exon 14 of 14 | NP_000320.1 | Q16518 | ||
| RPE65 | c.1435C>T | p.Arg479Trp | missense | Exon 13 of 13 | NP_001393782.1 | ||||
| RPE65 | c.1267C>T | p.Arg423Trp | missense | Exon 13 of 13 | NP_001393785.1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RPE65 | TSL:1 MANE Select | c.1543C>T | p.Arg515Trp | missense | Exon 14 of 14 | ENSP00000262340.5 | Q16518 | ||
| RPE65 | n.*1448C>T | non_coding_transcript_exon | Exon 15 of 15 | ENSP00000519233.1 | A0AAQ5BH58 | ||||
| RPE65 | n.*691C>T | non_coding_transcript_exon | Exon 13 of 13 | ENSP00000519234.1 | A0AAQ5BH46 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152074Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000804 AC: 2AN: 248882 AF XY: 0.00000743 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461552Hom.: 0 Cov.: 31 AF XY: 0.0000289 AC XY: 21AN XY: 727070 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74280 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at